DE50111495D1 - Artificial oxygen carriers from cross-linked modified human or porcine hemoglobin, processes for their preparation of purified material, and the use thereof - Google Patents

Artificial oxygen carriers from cross-linked modified human or porcine hemoglobin, processes for their preparation of purified material, and the use thereof

Info

Publication number
DE50111495D1
DE50111495D1 DE2001511495 DE50111495A DE50111495D1 DE 50111495 D1 DE50111495 D1 DE 50111495D1 DE 2001511495 DE2001511495 DE 2001511495 DE 50111495 A DE50111495 A DE 50111495A DE 50111495 D1 DE50111495 D1 DE 50111495D1
Authority
DE
Germany
Prior art keywords
processes
preparation
cross
use
purified material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE2001511495
Other languages
German (de)
Inventor
Wolfgang Barnikol
Oswald Burkhard
Harald Poetzschke
Ulrike Domack
Stephanie Dinkelmann
Bernd Fiedler
Birgit Manz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanguibiotech AG
Original Assignee
Sanguibiotech AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE2000131740 priority Critical patent/DE10031740A1/en
Application filed by Sanguibiotech AG filed Critical Sanguibiotech AG
Priority to PCT/EP2001/006613 priority patent/WO2002000230A1/en
Priority to DE2001511495 priority patent/DE50111495D1/en
Application granted granted Critical
Publication of DE50111495D1 publication Critical patent/DE50111495D1/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
DE2001511495 2000-06-29 2001-06-12 Artificial oxygen carriers from cross-linked modified human or porcine hemoglobin, processes for their preparation of purified material, and the use thereof Active DE50111495D1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE2000131740 DE10031740A1 (en) 2000-06-29 2000-06-29 Artificial oxygen carriers from cross-linked modified human or porcine hemoglobin having improved properties, to processes for their technically simple production of purified material in high yields, and the use thereof
PCT/EP2001/006613 WO2002000230A1 (en) 2000-06-29 2001-06-12 Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof
DE2001511495 DE50111495D1 (en) 2000-06-29 2001-06-12 Artificial oxygen carriers from cross-linked modified human or porcine hemoglobin, processes for their preparation of purified material, and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2001511495 DE50111495D1 (en) 2000-06-29 2001-06-12 Artificial oxygen carriers from cross-linked modified human or porcine hemoglobin, processes for their preparation of purified material, and the use thereof

Publications (1)

Publication Number Publication Date
DE50111495D1 true DE50111495D1 (en) 2007-01-04

Family

ID=7647244

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2000131740 Withdrawn DE10031740A1 (en) 2000-06-29 2000-06-29 Artificial oxygen carriers from cross-linked modified human or porcine hemoglobin having improved properties, to processes for their technically simple production of purified material in high yields, and the use thereof
DE2001511495 Active DE50111495D1 (en) 2000-06-29 2001-06-12 Artificial oxygen carriers from cross-linked modified human or porcine hemoglobin, processes for their preparation of purified material, and the use thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE2000131740 Withdrawn DE10031740A1 (en) 2000-06-29 2000-06-29 Artificial oxygen carriers from cross-linked modified human or porcine hemoglobin having improved properties, to processes for their technically simple production of purified material in high yields, and the use thereof

Country Status (7)

Country Link
US (1) US7005414B2 (en)
EP (1) EP1294386B1 (en)
AT (1) AT345806T (en)
AU (1) AU8385701A (en)
DE (2) DE10031740A1 (en)
ES (1) ES2275712T3 (en)
WO (1) WO2002000230A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306166B1 (en) * 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
DE10031744A1 (en) * 2000-06-29 2002-01-17 Sanguibio Tech Ag With blood plasma acceptable, crosslinked and conjugated with polyalkylene oxides mammalian hemoglobins as artificial medical oxygen carrier, their preparation and their use
DE20017940U1 (en) 2000-10-19 2000-12-28 Map Gmbh Respiratory mask for supplying a respiratory gas to a mask user, as well as discharge means for discharging breathing gas
CN105536116A (en) 2002-09-06 2016-05-04 瑞思迈有限公司 Forehead pad for respiratory mask
AT473774T (en) 2001-10-22 2010-07-15 Map Medizin Technologie Gmbh medical mask
DE10151984C5 (en) * 2001-10-22 2008-07-17 Map Medizin-Technologie Gmbh Application device for a breathing mask arrangement
DE10201682A1 (en) 2002-01-17 2003-07-31 Map Medizin Technologie Gmbh The breathing mask arrangement
DE10220992A1 (en) * 2002-05-11 2003-12-04 Sanguibiotech Ag Using one or more oxygen carrier selected from hemoglobin, myoglobin and derivatives thereof for the treatment of organ dysfunction following acute supply shortage and for the treatment / prevention of tissue damage due to such a disturbance
DE10352692A1 (en) * 2003-11-12 2005-06-23 Sanguibiotech Gmbh Using hypo-oncotic solutions addierbarer in the blood, hyper hemoglobins for the treatment of pulmonary edema
NZ597302A (en) 2004-06-16 2013-08-30 Resmed Ltd Cushion for a respiratory mask assembly
US9192697B2 (en) * 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
DE112008000881A5 (en) 2007-01-21 2010-01-21 Hemoteq Ag Medical device for treating obstructions of body passages and prevent the threat of re-closures
DE102008027133A1 (en) 2008-05-30 2009-12-03 Ls Medcap Gmbh Fully synthetic albumin analogue
WO2011008393A2 (en) * 2009-07-17 2011-01-20 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
WO2011081712A1 (en) * 2009-12-31 2011-07-07 Boston Scientific Scimed, Inc. Cryo activated drug delivery and cutting balloons
ES2370221B1 (en) * 2010-05-20 2012-08-16 Universidad De Huelva forest insect attractant composition.
US20120028899A1 (en) * 2010-07-30 2012-02-02 Andre Francis Palmer Composition and process for synthesizing tense and relaxed state polymerized hemoglobin
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US8609815B2 (en) 2010-09-02 2013-12-17 Sangart, Inc. Methods for preparing stable deoxygenated PEG-hemoglobin conjugate solutions comprising an antioxidant
EP2550973B1 (en) 2011-07-23 2013-08-28 SastoMed GmbH Wound spray
US8669360B2 (en) 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
EP2614833A1 (en) 2012-01-13 2013-07-17 SastoMed GmbH Scarring reducing wound treatment
KR20150132235A (en) 2013-03-15 2015-11-25 쉰들러, 윌리엄 Polyalkylene oxide valerate hemoglobin conjugates
DE102013014651A1 (en) 2013-09-03 2015-03-05 Sanguibiotech Gmbh Preparations for improved tissue oxygenation by peritoneal ventilation
EP3092213A4 (en) 2013-12-27 2017-08-23 Virginia Commonwealth University Allosteric hemoglobin modifiers with nitric oxide releasing moiety
EP3421044A1 (en) 2017-06-26 2019-01-02 SastoMed GmbH Oxygen carriers for the treatment of skin indispositions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE449885C (en) 1925-04-16 1927-09-22 Emil Zbinden Means for raising the driving forces behind the movements of time switches and similar devices
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4001200A (en) 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
DE2616086C2 (en) 1976-04-13 1986-04-03 Dr. Eduard Fresenius, Chemisch-Pharmazeutische Industrie Kg, 6380 Bad Homburg, De
US4179637A (en) * 1978-04-14 1979-12-18 Santora James V Incandescent light bulb with multiple filaments providing multiple lives
JPS6023084B2 (en) 1979-07-11 1985-06-05 Ajinomoto Kk
JPH026337B2 (en) 1981-06-10 1990-02-08 Ajinomoto Kk
DE3130770C2 (en) 1981-08-04 1986-06-19 Biotest-Serum-Institut Gmbh, 6000 Frankfurt, De
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
NL8503077A (en) 1985-11-08 1987-06-01 Grasso Koninkl Maschf Cooling equipment.
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US5386014A (en) * 1989-11-22 1995-01-31 Enzon, Inc. Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
US5312808A (en) * 1989-11-22 1994-05-17 Enzon, Inc. Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
US5234903A (en) 1989-11-22 1993-08-10 Enzon, Inc. Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
US5439882A (en) * 1989-12-29 1995-08-08 Texas Tech University Health Sciences Center Blood substitute
SE9001378D0 (en) 1990-04-18 1990-04-18 Kabivitrum Ab A method for the preparation of pyridoxylated hemoglobin
EP0854151A1 (en) 1997-01-20 1998-07-22 SanguiBioTech AG Process for the preparation of uniform fractions of hyperpolymers of haemoglobin

Also Published As

Publication number Publication date
AU8385701A (en) 2002-01-08
EP1294386B1 (en) 2006-11-22
AT345806T (en) 2006-12-15
ES2275712T3 (en) 2007-06-16
US20040029780A1 (en) 2004-02-12
US7005414B2 (en) 2006-02-28
WO2002000230A1 (en) 2002-01-03
DE10031740A1 (en) 2002-02-14
EP1294386A1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
DE60221637D1 (en) Stent with channels for the attitude and administration of biologically active material and method for its preparation
DE69930434D1 (en) Stent-graft-membrane and methods for their preparation
DE60039873D1 (en) Disposable underpants and process for their manufacture
DE69941696D1 (en) Microneedle devices and methods for their preparation
DE69934499D1 (en) An implantable stent and method for its manufacture
DE60141706D1 (en) Compounds having fungicidal activity and processes for their preparation and use
DE50015883D1 (en) Areal implant, process for its preparation and use in surgery
DE50308332D1 (en) Composite membrane and process for their preparation
DE69531705D1 (en) Fine zinc oxide particles, processes for their preparation and their use
AT235438T (en) Airgel and adhesive-containing composite material, process for its manufacture and its use
AT297247T (en) Fabric Translucent composite material, process for its manufacture and use of permeable composite
DE69536014D1 (en) uses methods for preparing enriched hematopoietic compositions, characterized compositions prepared and their
DE69922086D1 (en) Custom Function alloy, their use and processes for their preparation
DE69840739D1 (en) Method and composition for the production of mature dendritic cells
DE69828429D1 (en) Balloon catheter and manufacturing processes for
DE50213536D1 (en) Xanthine derivatives and their use as a medicament A method for the preparation thereof
AT257722T (en) Catheter and method for its manufacture
AT555062T (en) Stabilized brominlösungen, methods for production and use in the bioverschmutzungsüberwachung
DE69827259D1 (en) Compositions layers of alkoxysilane-organic polymer for the preparation of thin insulating and their use
AT524541T (en) Cultured epidermal cell layer, laminated cultured skin layer and process for their preparation
DE60137426D1 (en) 1,2-dihydropyridine compounds, processes for their preparation and their use
AT325085T (en) Microcrystalline alpha al2o3 molded articles, methods for their manufacture and their use
AT259904T (en) Individually protected litze, their use in the construction technology and methods for their preparation
DE69814891D1 (en) Composite reverse osmosis membrane and process for their manufacture
AT409023T (en) Drug delivery systems with delayed release, use and method for making same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition